Comparison

SB 202190 hydrochloride European Partner

Item no. TMO-T35592-200mg
Manufacturer TargetMol
CASRN 350228-36-3
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles Cl.FC=1C=CC(=CC1)C=2NC(=NC2C=3C=CN=CC3)C=4C=CC(O)=CC4
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias SB 202190 HCl
Shipping Condition Cool pack
Available
Manufacturer - Targets
p38 MAPK
Storage Conditions
-20
Molecular Weight
367.8
Description
SB 202190 hydrochloride is the salt form of SB 202190.SB 202190 (FHPI) is a p38 MAPK inhibitor that inhibits p38α and p38β2 with selective, cell-permeable, and antitumor activity, and also induces differentiation of human embryonic stem cells to cardiomyocytes.
Pathways
MAPK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close